Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2012

GlobalData, January 2012, Pages: 88

Wilms’ Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Wilms’ Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2012" provides data on the Wilms’ Tumor (Nephroblastoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wilms’ Tumor (Nephroblastoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wilms’ Tumor (Nephroblastoma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Wilms’ Tumor (Nephroblastoma) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Wilms’ Tumor (Nephroblastoma) , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Wilms’ Tumor (Nephroblastoma)
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Wilms’ Tumor (Nephroblastoma)
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Jennerex Biotherapeutics, Inc.
Clinical Trial Overview of Jennerex Biotherapeutics, Inc.
Talon Therapeutics, Inc.
Clinical Trial Overview of Talon Therapeutics, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
St. Jude Children’s Research Hospital, Inc.
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc.
Emory University
Clinical Trial Overview of Emory University
Children's Hospital Center for Cancer and Blood Disorders
Clinical Trial Overview of Children's Hospital Center for Cancer and Blood Disorders
University of Munster
Clinical Trial Overview of University of Munster
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
University Hospital Hamburg-Eppendorf
Clinical Trial Overview of University Hospital Hamburg-Eppendorf
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, North America, Top Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, G7 Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Talon Therapeutics, Inc., 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Center for Cancer and Blood Disorders, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Hamburg-Eppendorf, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-

List of Figures
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, G7 Countries (%), 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Wilms’ Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Strabismus Global Clinical Trials Review, H1, 2013
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Cholangitis Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Ulcers Global Clinical Trials Review, H1, 2013
• Alopecia Global Clinical Trials Review, H1, 2013
• Otitis Media Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Peptic Ulcers Global Clinical Trials Review, H2, 2012
• Hemostasis Global Clinical Trials Review, H1, 2013